Development of the drug oncolytic immunotherapy based on vaccinia viruses <i>(Vaccinia virus, Orthopoxvirus, Chordopoxvirinae, Poxviridae)</i> against breast cancer

Introduction. Currently, new directions in cancer therapy are actively developing, one of which is oncolytic immunotherapy. This approach would be to use of viruses as cancer specific cytolytic agents capable of stimulating both the tumor-specific and non-specific immune response. The objective pap...

Popoln opis

Bibliografske podrobnosti

Principais autores:	T. V. Bauer, T. V. Tregubchak, A. Z. Maksyutov, R. A. Maksyutov, I. V. Kolosova, E. V. Gavrilova
Format:	Artigo
Jezik:	Inglês
Izdano:	Central Research Institute for Epidemiology 2020-02-01
Serija:	Вопросы вирусологии
Teme:	oncolytic virus vaccinia virus tumor-associated antigen cytotoxic t-lymphocyte breast cancer
Online dostop:	https://virusjour.crie.ru/jour/article/viewFile/267/163
Oznake:	Označite Brez oznak, prvi označite!